TABLE 3

Secondary outcomes: physical impairment and organ function

OutcomeCorticosteroidsNo corticosteroidsp-value
Subjects737.5488.9
ISWT distance, m462.78±468.30455.15±252.130.770
ISWT % pred62.59±59.2560.59±28.720.604
SPPB total score10.12±1.999.93±2.320.160
SPPB (mobility disability ≤10)Yes289.4 (39.2)219.0 (44.8)0.671
No325.1 (44.1)233.1 (47.7)
Missing122.9 (16.7)36.8 (7.5)
FEV1 % pred <80%Yes78.1 (10.6)70.3 (14.4)0.613
No258.1 (35.0)210.6 (43.1)
Missing data401.3 (54.4)208.0 (42.5)
FVC % pred <80%Yes85.1 (11.5)74.3 (15.2)0.772
No251.1 (34.0)207.3 (42.4)
Missing data401.3 (54.4)207.3 (42.4)
FEV1/FVC <0.7Yes32.5 (4.4)31.1 (6.4)0.606
No310.6 (42.1)257.8 (52.7)
Missing data394.4 (53.5)200.0 (40.9)
KCO <80% predYes15.6 (2.1)9.3 (1.9)0.287
No103.6 (14.0)98.0 (20.1)
Missing data618.3 (83.8)381.6 (78.0)
TLCO <80% predYes19.2 (2.6)27.7 (5.7)0.074
No92.4 (12.5)71.4 (14.6)
Missing data625.8 (84.9)389.8 (79.7)
BNP ≥100 ng·L−1 or NT-proBNP ≥400 ng·L−1Yes23 (3.2)24 (4.9)0.529
No292 (39.9)229 (46.3)
Missing data416 (56.9)242 (48.9)
HbA1C ≥6.0% (DCCT/NGSP)Yes157 (21.5)114 (23.0)0.881
No277 (37.9)196 (39.6)
Missing data297 (40.6)185 (37.4)
eGFR <60 mL·min−1 per 1.73 m2Yes74 (10.1)63 (12.7)0.586
No475 (65.0)321 (64.8)
Missing data182 (24.9)111 (22.4)
C-reactive protein concentration >5 mg·L−1Yes124 (17.0)78 (15.8)0.204
No423 (57.9)321 (64.8)
Missing data184 (25.2)96 (19.4)
Fibrinogen (g·L−1)3.58±2.233.56±0.870.846

Data are n, n (%) or mean±sd. Percentages are calculated by category after exclusion of missing data for that variable. BNP: brain natriuretic peptide; DCCT: Diabetes Control and Complications Trial; eGFR: estimated glomerular filtration rate; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; HbA1C: haemoglobin A1C; ISWT: incremental shuttle walk test; KCO: carbon monoxide transfer coefficient; NGSP: National Glycohemoglobin Standardization Program; NT-proBNP: N-terminal pro-brain natriuretic peptide; SPPB: Short Physical Performance Battery; TLCO: transfer factor of the lung for carbon monoxide.